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PPRECLINICAL STUDY
Recipient Age Determines
the Cardiac Functional Improvement
Achieved by Skeletal Myoblast Transplantation
Chung-Dann Kan, MD,*† Shu-Hong Li, MSC,* Richard D. Weisel, MD,* Shun Zhang, BSC,*
Ren-Ke Li, MD, PHD*
Toronto, Ontario, Canada; and Taiwan, Republic of China
Objectives The aim of the current study was to evaluate the effect of recipient age on the regenerative response to implan-
tation with young skeletal myoblasts (SKMCs) after a coronary artery ligation.
Background In contrast with previous findings in animals, the initial clinical trials of cell transplantation after a myocardial
infarction have reported only limited improvements in ventricular function. The restricted regenerative capacity
of cells isolated from older patients is certainly a factor; however, the present study investigated the impact of
another potentially significant factor: recipient age.
Methods We compared the myogeneic capacities of SKMCs isolated from young rats (3 months old) and older rats (24
months old). Highly myogenic SKMCs derived from young rats (or culture media, in control rats) were then trans-
planted into the infarcted myocardium of young and older recipients at 1 week after coronary ligation.
Results In vitro, proliferation and myotube formation were significantly greater in SKMCs derived from young rats than
from older rats. In vivo, young and older recipients of SKMCs exhibited increases in cell density, vascular density,
and collagen preservation relative to age-matched control animals. However, cell therapy produced significantly
greater functional improvements in young recipients than in older, along with relative increases in stem cell fac-
tor, cell density, cell survival, and angiogenesis.
Conclusions Functional improvement after the post–myocardial infarction implantation of young SKMCs was limited in older
recipients, likely due to reductions in their cardiac and systemic responses to cell transplantation. (J Am Coll
Cardiol 2007;50:1086–92) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.06.009c
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ation of ventricular morphometry and function in the
nfarcted heart after implantation of skeletal myoblasts
SKMCs), endothelial progenitor cells, or bone marrow
ells (1–3). However, preliminary clinical trials using autol-
gous SKMCs, bone marrow-derived stem cells, or progen-
tor cells to treat patients suggest that the benefits of
mplanting cells from middle-aged or older patients are
ignificantly limited compared with those obtained in pre-
linical studies with cells from young animals (4).
rom the Division of Cardiovascular Surgery, Toronto General Research Institute,
niversity of Toronto, Toronto, Ontario, Canada; and the †Department of Surgery,
ational Cheng Kung University Hospital Institute of Clinical Medicine, Cardio-
ascular Research Center, Medical College, National Cheng Kung University,
aiwan, Republic of China. Support for this study was received from the Heart and
troke Foundation of Ontario (NA 5294, T 5206) and the Canadian Institutes for
ealth Research (MOP 62698, MOP 14795). Dr. Li is a Career Investigator of the
eart and Stroke Foundation of Canada and holds a Canada Research Chair in
ardiac regeneration.C
Manuscript received March 20, 2007; revised manuscript received June 4, 2007,
ccepted June 5, 2007.Several reports have proposed that the age of the donor
ells may have restricted the effectiveness of cell implanta-
ion in some of the clinical trials (5–8). We attempted to
etermine the contribution of another potentially significant
actor, recipient age, on the functional response to the
mplantation of young, healthy cells after a myocardial
nfarction (MI).
In the current study, we characterized SKMCs isolated
rom young and older donor rats, then transplanted highly
yogenic SKMCs from young rats into the infarcted
yocardium of young and older recipient rats. We hypoth-
sized that an age-related deficiency in the intrinsic regen-
rative response to injury might limit the effects of cell
ransplantation in older individuals.
ethods
nimals. Inbred male Fisher rats (3 months old  young;
4 months old  older; U.S. National Institute of Aging)
ere used as donor and recipient animals. All procedures
ere performed with the approval of the Animal Care
ommittee of the Toronto General Research Institute.
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September 11, 2007:1086–92 Recipient Response to Cell Therapy Is Age RelatedKMC growth and myotube formation studies. Skeletal
yoblast cells were isolated from young and older rats as
reviously described (8). Cell culture, myotube formation, and
ell growth study were carried out as described in Appendix
1. Myotubes formed by the SKMCs were identified by
mmunohistochemical staining using antibodies against myo-
in heavy chain (MHC) (1:50) (Santa Cruz, Santa Cruz,
alifornia) and desmin (1:2,000) (Sigma, Toronto, Ontario,
anada) performed according to manufacturer’s protocols.
I. Myocardial infarction was generated in young and
lder rats by ligation of the left anterior descending artery as
escribed previously (8) and in Appendix E1.
ell preparation and transplantation. Since the focus of
he current study was on the effect of recipient age, rather
han cell donor age, on the efficacy of cell therapy, recipients
rom both age groups received highly myogenic SKMCs
solated from young donor rats. The SKMCs were labelled
efore transplantation for cell identification as described in
ppendix E1.
One week after ligation, echocardiography was performed
nd rats were selected to minimize variation (8). Young and
lder rats with infarct lengths between 0.7 and 1.2 cm and
ercent fractional area change (%FAC) between 20% and
0% were divided into 4 groups: young and older recipients
f SKMCs isolated from young donors; young and older
ecipients of culture media (control animals). In each rat,
ells (3  106 cells per rat; n  9 rats per age group) or
ulture media (n  6 rats per age group) were injected into
he central infarcted region as previously described (8).
Figure 1 SKMCs in Culture
Light photomicrographs (100) illustrating the morphology of cultured skeletal my
(F to J) rats, at passages 1 through 5 (P1 to P5). (K) Growth rate of SKMCs isolaardiac function. Before and 1
eek after coronary ligation (be-
ore cell transplantation) and 4
eeks after cell transplanta-
ion, echocardiography was per-
ormed. Left ventricular diastolic
nd systolic dimensions and areas
ere measured, and percent frac-
ional shortening (FS), percent
jection fraction (EF), and
FAC were calculated as de-
cribed in Appendix E1.
Cardiac function and ventric-
lar volumes were also evaluated at 4 weeks after cell
ransplantation using a pressure-volume catheter, as de-
cribed in Appendix E1. Pressure–volume loops were used
o quantify stroke work.
istology and immunohistochemistry. At 4 weeks after
ransplantation, hearts were fixed in 10% formaldehyde and
ectioned. Sections were stained with Masson trichrome or
erheoff’s Van Geison stain, or immunohistochemically
tained for von Willebrand factor or bromodeoxyuridine
BrdU), according to manufacturer’s protocols. Four or 5
elds from each of 5 sections per animal were randomly
elected for analysis as described in Appendix E1. Counts
ere expressed as the number of nuclei (cell density), blood
essels (vascular density), or BrdU nuclei (implanted cell
urvival), or the percentage collagen preservation per
.2 mm2.
cells (SKMCs) derived from young (A to E) and older
m young and older rats at P1 to P5. Arrows  myotube structures.
Abbreviations
and Acronyms
EF  ejection fraction
FAC  fractional area
change
FS  fractional shortening
MHC  myosin heavy chain
MI  myocardial infarction
SCF  stem cell factor
SKMC  skeletal myoblastoblast
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Recipient Response to Cell Therapy Is Age Related September 11, 2007:1086–92tem cell factor (SCF) protein levels. Stem cell factor
evels were measured in the central and peripheral infarcted
egions of animals in all groups (n 4/group) at 7 days after
ell or media implantation using a commercially available
nzyme-linked immunoabsorbent assay kit (R&D Systems,
inneapolis, Minnesota) according to manufacturer’s
rotocols.
tatistical analyses. All data are expressed as mean 
tandard error (SEM). Multiple group comparisons were
Figure 2 Cell Differentiation and Myotube Formation
Light photomicrographs (100) showing cultured cells derived from young and
older rats, stained for myosin heavy chain (MHC) and desmin at passages 1
(P1) (A to D) and 5 (P5) (E to H). (I) The number of myotubes in cell cultures
derived from young and older rats at passages 1 and 5. *p  0.01 compared
with same group at P1.
ardiac Function by Echocardiography
Table 1 Cardiac Function by Echocardiography
Parameter Group Baseli
FS Older control 53.63
Older SKMC 55.05
Young control 57.88
Young SKMC 53.57
FAC Older control 50.59
Older SKMC 51.32
Young control 56.86
Young SKMC 57.39
EF Older control 78.10
Older SKMC 79.07
Young control 82.17
Young SKMC 78.29
ean values and standard errors for fractional shortening (FS), fractional area change (FAC), and
oronary ligation (before cell or media implantation [pre-TX]), and 4 weeks after implantation (pos
nalysis of variance with least squares difference multiple range tests revealed no differences am
easures were significantly lower in older control relative to older SKMC group ( ‡ vs. §,  vs. ¶, †† vs. ‡‡;
# vs. , §§ vs. ; p  0.05).erformed by analysis of variance, using the SPSS software
version 12.0, SPSS Inc., Chicago, Illinois). When F values
ere significant (p 0.05), the differences were specified by
post-hoc evaluation with Tukey’s and/or least squares
ifference multiple range tests. Survival data were depicted
ith Kaplan-Meier survival curves, and differences between
roups were determined by log-rank statistics. Statistical
ignificance was assumed when p  0.05.
esults
n vitro study. SKMCs ISOLATED FROM YOUNG DONORS
XHIBITED THE GREATER MYOGENIC POTENTIAL. The
orphologies of SKMCs cultured from young and older
ats were similar (Figs. 1A to 1J). Proliferation rates of cells
erived from young animals were significantly greater (p 
.05) than those of cells from older animals at passages 1
Figure 3 Post-Infarction Survival Rates
Survival rates over 5 weeks (35 days) after myocardial infarction (MI) in young
rats implanted with young skeletal myoblasts (young SKMC) or culture media
(young control), and older rats implanted with young SKMCs (older SKMC) or
media (older control), expressed as a percentage of total animals in each group.
Pre-TX† Post-TX
24.76 2.42 17.84 1.60‡
25.02 1.47 27.15 1.73§
23.53 0.46 23.44 1.58
21.98 0.36 29.25 2.48§
27.69 0.90 22.57 2.91
35.73 1.71 34.93 1.53¶
30.40 1.69 25.29 1.98¶#
30.58 1.39 35.21 1.09¶
42.51 3.64 36.81 1.44††
43.64 2.22 46.89 2.44‡‡
41.29 0.67 41.18 2.49§§
39.30 0.53 49.45 3.33‡‡,
n fraction (EF) measured by echocardiography before coronary ligation (baseline), 1 week after
young and older rats implanted with young skeletal myoblasts (SKMC) or culture media (control).
roups in FS, FAC, and EF at baseline or pre-TX (  and †; p  0.05). In contrast, at post-TX, all 3ne
4.09
1.94
1.22
0.98
0.92
2.59
2.88
2.33
3.78
1.59
1.13
0.88
ejectio
t-TX) in
ong gp 0.05), and FAC and EF were significantly lower in young control relative to young SKMC group
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September 11, 2007:1086–92 Recipient Response to Cell Therapy Is Age Relatednd 2, but were similar between groups at later passages (n
5/group/time point) (Fig. 1K).
To evaluate cell differentiation, cells from each passage at
0% confluency were cultured in a 5% fetal bovine solution
edium for 7 days. In both young and older animals, cells
ositive for MHC or desmin decreased from more than 90%
o 80% or nearly zero, respectively, by passage 5 (Figs. 2A to
H). Myotube formation was observed in all cell cultures,
hough numbers were significantly greater (p  0.01) in
ells derived from young relative to older animals. Numbers
f myotubes and spontaneously beating myotubes decreased
ignificantly (p  0.01) by passage 5 in both age groups
n  5/group/time point) (Fig. 2I).
n vivo study. THE FUNCTIONAL EFFECTS OF YOUNG
KMCs WERE DEPENDENT ON RECIPIENT AGE. Survival: all
f the young rats survived for the 35-day period after MI. In
omparison, the survival rate was significantly lower (p 
.05) for older control rats (70%). Skeletal myoblast cell
mplantation appeared to increase survival in older recipi-
nts relative to control animals, but the improvement did
ot reach significance (p  0.07) (Fig. 3).
Cardiac function: cardiac function was evaluated by echo-
ardiography (before ligation, before transplantation, 4
eeks after transplantation) and pressure-volume catheter
easurements (4 weeks after transplantation).
Echocardiography: %FS, %FAC, and %EF decreased sig-
ificantly in all groups at 1 week after ligation (Table 1),
ith no differences among groups. After media implanta-
ion, cardiac function continued to decrease in both control
roups. This deterioration was diminished in the older
ecipients of SKMCs, and was reversed in the young
ecipients after SKMC implantation.
Differences between each functional measure before and
fter implantation were calculated for each rat, and showed
hat function deteriorated progressively (p  0.05) after
mplantation in both young and older control groups, but
he heart failure was more severe (p  0.05) in the older
ats. Cardiac function improved in all recipients of SKMCs,
ut the improvement was greater (p  0.05) in the young
ompared with the older recipients (Fig. 4).
Pressure-volume measurement: functional evaluation con-
rmed improved (p  0.05) stroke work and negative
aximum derivative of pressure divided by derivative of
ime in the young compared with the older recipients of
KMCs. Cell implantation decreased both left ventricular
nd-systolic volume and left ventricular end-diastolic vol-
me (p  0.05) in the young recipients of SKMCs, but not
n the older recipients (online Fig. E1 [see Appendix]).
LDER RECIPIENTS OF SKMCs EXHIBITED A LIMITED REGEN-
RATIVE RESPONSE TO CELL THERAPY AFTER AN MI.
ellularity: Masson trichrome staining suggested that the
ensity of cells within the infarcted region was signifi-
antly greater (p  0.05) in young and older rats that
eceived SKMC implantation compared with the controlnimals. Quantification indicated greater (p  0.05) cell
ensity in young compared with older SKMC recipients
Fig. 5).
Implanted cell survival rate: BrdU immunostaining iden-
ified the implanted SKMCs 4 weeks after transplantation.
rdU signals were identified within the infarcted regions of
KMC recipients only, and positive cell counts suggested
reater (p  0.05) implanted cell survival in the young
ompared with the older recipients (Fig. 6).
Stem cell factor: stem cell factor protein levels measured in
he infarcted myocardium at 1 week after implantation were
ignificantly greater (p  0.05) in young compared with
lder control animals (media recipients). The implantation
f SKMCs significantly increased (p  0.01) SCF levels
Figure 4 Cardiac Functional Change by Echocardiography
Changes in percent fractional shortening (FS) (A), percent fractional area
change (FAC) (B), and percent ejection fraction (EF) (C) measured immediately
before cell or media implantation (pre-TX) and 4 weeks after implantation (post-
TX), in young rats implanted with young skeletal myoblasts (young SKMC) or
culture media (young control), and older rats implanted with young SKMCs
(older SKMC) or media (older control). *p  0.05 compared with older SKMC
group; #p  0.05 compared with corresponding control group; †p  0.05 com-
pared with older control group.
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Recipient Response to Cell Therapy Is Age Related September 11, 2007:1086–92relative to control animals) in both young and older
ecipients, but protein levels were greater (p  0.01) in the
oung than in the older recipients (online Fig. E2 [see
ppendix]).
Vasculogenesis: von Willebrand factor staining identified
ore vascular structures in the peripheral infarcted region of
oung than older recipients of SKMCs (p  0.05) at 4
eeks after implantation, and both groups exhibited greater
p  0.01) vascular densities than the control groups
Fig. 7).
Collagen: Verhoeff’s Van Geison staining indicated sig-
ificantly more (p  0.01) collagen in the central infarcted
egion of SKMC recipients compared with control animals
t 4 weeks after implantation, but the magnitude of pres-
rvation was not affected by age (Fig. 8).
iscussion
one marrow stem cells and circulating progenitor cells
Figure 5 Histologic Study of Implanted Cells at
4 Weeks After Cell or Media Implantation
(A to D) Light photomicrographs (100) illustrating cellular density (Masson
trichrome staining; arrows  cell clusters) in the central infarcted region of
young and older rats implanted with young skeletal myoblasts (SKMCs) or
media (controls). (E) Quantification of cellular density in each group: young rats
implanted with young SKMCs (young SKMC) or culture media (young control),
and older rats implanted with young SKMCs (older SKMC) or media (older
control).solated from older individuals demonstrate weakened re-enerative capacities that may contribute to a decline in the
ardiac functional response to cell therapy (5–8). In the
urrent study, we demonstrated that recipient age is another
mportant determinant of this response. The implantation
f young, healthy SKMCs produced significantly greater
unctional improvements in young than in older cell
ecipients.
Of several reports that age decreases the number and
roliferative potential of stem cells and contributes to the
ariable results of clinical cell therapy trials in aging patients,
ost have focused on bone marrow stem cells, circulating
tem cells, or cardiac cells (6–9). Skeletal myoblast cells
ave been employed effectively to restore cardiac function in
reclinical studies (10), and have been evaluated in clinical
rials, but few studies have reported the effect of age on their
yogenic capacity. The transplantation of cells from older
ndividuals was not the focus of this study. However, we
Figure 6 Cell Survival at 4 Weeks
After Cell or Media Implantation
(A to D) Light photomicrographs illustrating the localization of bromodeoxyuri-
dine (BrdU) prelabeled skeletal myoblasts (SKMC) (arrows) isolated from
young donors, implanted into the central infarcted myocardium of young and
older rats. Areas inside black borders in A and B (100) are shown at higher
power (400) in C and D. (E) Quantification of surviving BrdU cells in each
group: young rats implanted with young SKMCs (young SKMC), and older rats
implanted with young SKMCs (older SKMC).
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September 11, 2007:1086–92 Recipient Response to Cell Therapy Is Age Relatedemonstrated the diminished proliferative and myogenic
apacity of SKMCs isolated from older rats. These findings
re in agreement with those reported by Conboy et al. (11).
The mechanisms responsible for the limited regeneration
n older recipients after the transplantation of young
KMCs likely include both cardiac and systemic responses
o cell implantation. After an MI, we observed no morbidity
r mortality in young rats, but ventricular rupture and heart
ailure were frequent in older rats even after cell implanta-
ion. Limitations in systemic responses such as endothelial
rogenitor cell mobilization may have restricted ventricular
unctional recovery in the older rats through changes to the
ollowing processes:
. SCF levels: SCF is important for progenitor cell recruit-
ment after an MI (12). Here, lower overall SCF protein
levels in the older compared with the young recipients of
SKMCs could have limited bone marrow stem cell
mobilization, homing and engraftment in the damaged
myocardium, thereby reducing neovascularization (12).
. Angiogenesis: blood vessel density was considerably less
Figure 7 Vasculogenesis at 4 Weeks
After Cell or Media Implantation
(A to D) Light photomicrographs (100) illustrating blood vessels (von Wille-
brand factor staining; arrows) in the peripheral infarcted region of young and
older rats implanted with young skeletal myoblasts (SKMCs) or media (control).
(E) Quantification of vascular density in each group: young rats implanted with
young SKMCs (young SKMC) or culture media (young control), and older rats
implanted with young SKMCs (older SKMC) or media (older control).in the older compared with the young recipients ofSKMCs, suggesting that a limited angiogenic response
to cell transplantation may have restricted functional
recovery in the older recipients.
. Survival of implanted cells: the number of cells that
survive to engraft in the infarcted region determines the
extent of the paracrine signals that induce progenitor
cell recruitment, angiogenesis, and improved cardiac
function. We found fewer BrdU-positive cells in the
infarcted region of older compared with young recipi-
ents of SKMCs. Limited implanted cell survival might
have diminished the paracrine signals and limited func-
tional improvement.
yoblast-induced preservation of the collagen-integrin-
yocyte cytoskeletal complex may also account for the
unctional improvements associated with cell therapy. Col-
agen matrix preservation after cell implantation was dem-
nstrated in a hamster cardiomyopathy model (13). In the
resent study, SKMC implantation was associated with
nhanced collagen preservation compared with media injec-
ion. However, we did not observe a significant age effect.
Figure 8 Collagen Preservation at
4 Weeks After Cell or Media Implantation
(A to D) Light photomicrographs (100) illustrating collagen content (Ver-
heoff’s Van Geison staining) in the central infarcted region of young and older
rats implanted with young skeletal myoblasts (SKMCs) or media (control). (E)
Quantification of collagen content (percentage of the total scar area per sec-
tion stained positive for collagen) in each group: young rats implanted with
young SKMCs (young SKMC) or culture media (young control), and older rats
implanted with young SKMCs (older SKMC) or media (older control).
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Recipient Response to Cell Therapy Is Age Related September 11, 2007:1086–92onclusions
he beneficial effects of post-MI cell therapy using young
KMCs were decreased in older recipients. Future studies
ill be required to fully describe the nature of the age-
elated limitation of regenerative capacity, especially because
linical trials involving the transplantation of cells from
ounger patients (allogenic mesenchymal stromal cells or
KMCs) into older individuals have been proposed. An
nderstanding of the older recipients’ response to the
mplantation of healthy cells will be important to interpret
he results obtained.
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he authors acknowledge Heather McDonald Kinkaid for
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